| Not Yet Recruiting | A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiv Pneumonia, Bacterial | Phase 1 | 2026-07-10 |
| Not Yet Recruiting | A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian C Ovarian Neoplasms | Phase 3 | 2026-06-24 |
| Not Yet Recruiting | A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer Neoplasms, Endometrial | Phase 3 | 2026-06-09 |
| Not Yet Recruiting | A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to Pneumonia, Bacterial | Phase 1 | 2026-05-15 |
| Not Yet Recruiting | A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Measles | Phase 3 | 2026-04-13 |
| Not Yet Recruiting | A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowe Irritable Bowel Syndrome | Phase 2 | 2026-04-06 |
| Not Yet Recruiting | A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Po Herpes Zoster | Phase 4 | 2026-03-31 |
| Not Yet Recruiting | A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Re Urinary Tract Infections | Phase 1 | 2026-03-31 |
| Recruiting | First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Neoplasms | Phase 1 | 2026-03-23 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bort Amyloidosis | Phase 2 | 2026-03-20 |
| Recruiting | A Study of Efimosfermin Alfa in Adults With Hepatic Impairment Non-alcoholic Fatty Liver Disease | Phase 1 | 2026-03-13 |
| Recruiting | Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 6 Pneumonia, Bacterial | Phase 1 | 2026-03-10 |
| Recruiting | A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Influenza, Human+COVID-19 | Phase 1 | 2026-03-09 |
| Not Yet Recruiting | A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Typ Asthma | Phase 3 | 2026-03-06 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Adminis Non-alcoholic Fatty Liver Disease | Phase 1 | 2026-03-05 |
| Not Yet Recruiting | A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nont Salmonella Infections | Phase 2 | 2026-02-16 |
| Recruiting | A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD) Systemic Lupus Erythematosus | Phase 1 | 2026-02-10 |
| Recruiting | First-Time-in-Human Study of GSK5471713 in Adults With mCRPC Neoplasms, Prostate | Phase 1 / Phase 2 | 2026-02-10 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Pa Multiple Myeloma | Phase 2 | 2026-01-14 |
| Not Yet Recruiting | Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children Diarrhoea | Phase 2 | 2026-01-02 |
| Recruiting | Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient- Lung Cancer, Non-Small Cell | Phase 1 / Phase 2 | 2025-12-30 |
| Recruiting | A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants Wit Non-alcoholic Fatty Liver Disease | Phase 3 | 2025-12-12 |
| Recruiting | A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Neoplasms | Phase 1 | 2025-12-03 |
| Recruiting | A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors Aft Gastrointestinal Neoplasms | Phase 3 | 2025-12-03 |
| Recruiting | A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advance Neoplasms, Endometrial | Phase 2 | 2025-11-27 |
| Recruiting | A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adul Respiratory Syncytial Virus Infections | Phase 3 | 2025-10-29 |
| Recruiting | A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stag Non-alcoholic Fatty Liver Disease | Phase 3 | 2025-10-24 |
| Recruiting | A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other An Neoplasms, Colorectal, Neoplasms | Phase 1 / Phase 2 | 2025-10-20 |
| Recruiting | eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Di Pulmonary Disease, Chronic Obstructive | Phase 3 | 2025-10-20 |
| Active Not Recruiting | A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above Influenza, Human | Phase 2 | 2025-10-07 |
| Not Yet Recruiting | A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis Bronchiectasis | Phase 2 | 2025-09-26 |
| Recruiting | A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease Hepatitis B | Phase 1 | 2025-09-16 |
| Active Not Recruiting | A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Influenza, Human | Phase 2 | 2025-08-25 |
| Recruiting | Open-label Extension Study in Participants With Early Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2025-08-14 |
| Active Not Recruiting | A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To Pneumonia, Bacterial | Phase 1 | 2025-08-12 |
| Recruiting | A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) Neoplasms, Lung | Phase 3 | 2025-08-11 |
| Recruiting | A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Mon Malaria | Phase 2 | 2025-08-06 |
| Recruiting | A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vacc Respiratory Syncytial Virus Infections | Phase 2 | 2025-08-06 |
| Recruiting | A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Alu Streptococcal Infections | Phase 1 | 2025-07-31 |
| Not Yet Recruiting | A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endome Neoplasms, Endometrial | Phase 4 | 2025-07-15 |
| Recruiting | Depemokimab Asthma Imaging and Bronchoscopy Sub-Study Asthma | Phase 3 | 2025-07-11 |
| Active Not Recruiting | A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To Meningitis | Phase 3 | 2025-07-07 |
| Recruiting | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (C Pulmonary Disease, Chronic Obstructive | Phase 3 | 2025-06-23 |
| Recruiting | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (C Pulmonary Disease, Chronic Obstructive | Phase 3 | 2025-06-20 |
| Recruiting | A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Neoplasms, Prostate | Phase 1 / Phase 2 | 2025-06-12 |
| Recruiting | A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants Wi Gastrointestinal Neoplasms | Phase 1 / Phase 2 | 2025-06-11 |
| Recruiting | A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 2025-06-05 |
| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK386 Pulmonary Disease, Chronic Obstructive | Phase 1 | 2025-05-20 |
| Recruiting | A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Giv Chickenpox | Phase 3 | 2025-05-15 |
| Not Yet Recruiting | A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epi Ovarian Neoplasms | Phase 4 | 2025-04-22 |
| Recruiting | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mum Chickenpox | Phase 3 | 2025-04-17 |
| Completed | A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a Asthma | Phase 1 | 2025-03-11 |
| Active Not Recruiting | A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma | Phase 1 / Phase 2 | 2025-03-06 |
| Recruiting | A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors Tumours, Gynecological | Phase 1 / Phase 2 | 2025-03-04 |
| Recruiting | Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | Phase 2 | 2025-02-28 |
| Recruiting | A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untre Neoplasms, Colon | Phase 2 | 2025-02-17 |
| Active Not Recruiting | A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontr Asthma | Phase 2 | 2025-02-10 |
| Recruiting | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Child Chickenpox | Phase 3 | 2025-01-10 |
| Recruiting | A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus D Multiple Myeloma, Newly Diagnosed Multiple Myeloma | Phase 3 | 2024-12-16 |
| Active Not Recruiting | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in C Neoplasms, Colorectal, Solid Tumor, Colon Cancer | Phase 1 / Phase 2 | 2024-12-13 |
| Recruiting | A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease Connective Tissue Diseases | Phase 3 | 2024-12-12 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose Kidney Disease | Phase 1 | 2024-12-11 |
| Recruiting | A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Month Chickenpox | Phase 3 | 2024-11-26 |
| Recruiting | A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Urinary Tract Infections | Phase 1 / Phase 2 | 2024-11-19 |
| Active Not Recruiting | A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of Colitis, Ulcerative | Phase 1 | 2024-11-18 |
| Recruiting | An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Malaria, Vivax | Phase 3 | 2024-11-13 |
| Completed | A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in In Diarrhoea | Phase 2 | 2024-11-13 |
| Completed | A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults COVID-19 | Phase 1 | 2024-11-11 |
| Active Not Recruiting | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Chronic Hepatitis B Virus Infection, Hepatitis B | Phase 2 | 2024-11-11 |
| Active Not Recruiting | A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China Neoplasms, Rectal | Phase 2 | 2024-10-17 |
| Completed | A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participan Idiopathic Pulmonary Fibrosis | Phase 1 | 2024-10-07 |
| Recruiting | Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN Lupus Nephritis | — | 2024-10-04 |
| Completed | A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Urinary Tract Infections | Phase 3 | 2024-10-02 |
| Completed | A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Va Respiratory Syncytial Virus Infections | Phase 3 | 2024-10-01 |
| Recruiting | A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101) Neoplasms | Phase 1 | 2024-09-30 |
| Active Not Recruiting | A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged Respiratory Syncytial Virus Infections | Phase 1 | 2024-09-30 |
| Completed | A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Part Pulmonary Disease, Chronic Obstructive | Phase 1 | 2024-09-30 |
| Recruiting | A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged Liver Diseases, Alcoholic | Phase 2 | 2024-09-27 |
| Active Not Recruiting | Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus I Hepatitis B | Phase 2 | 2024-09-17 |
| Recruiting | A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Conne Lung Diseases, Interstitial | Phase 3 | 2024-09-11 |
| Recruiting | A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chines Systemic Lupus Erythematosus | Phase 1 | 2024-09-02 |
| Completed | Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participa Respiratory Tract Infections | Phase 1 | 2024-09-02 |
| Recruiting | A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Asthma, Mild Asthma | Phase 1 | 2024-08-14 |
| Completed | A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Resp Respiratory Syncytial Virus Infections | Phase 3 | 2024-08-05 |
| Active Not Recruiting | An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respirator Respiratory Syncytial Virus Infections | Phase 3 | 2024-08-01 |
| Completed | Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants Asthma | Phase 1 | 2024-07-29 |
| Completed | Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Hepatitis B | Phase 1 | 2024-07-18 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injecti Solid Tumors, Neoplasms | Phase 1 | 2024-07-02 |
| Active Not Recruiting | Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Bu Asthma | — | 2024-07-01 |
| Active Not Recruiting | A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Parti Lung Cancer, Non-Small Cell | Phase 3 | 2024-06-10 |
| Recruiting | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Systemic Lupus Erythematosus | Phase 4 | 2024-06-06 |
| Terminated | Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. Dermatitis, Atopic | Phase 2 | 2024-06-05 |
| Completed | A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Contai Asthma, Healthy Participants | Phase 1 | 2024-06-04 |
| Withdrawn | A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Autoimmune Diseases | Phase 1 | 2024-06-03 |
| Completed | A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via M Asthma | Phase 3 | 2024-05-31 |
| Completed | A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Y Influenza, Human | Phase 2 | 2024-05-23 |
| Active Not Recruiting | A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanc Carcinoma | Phase 2 | 2024-05-07 |
| Completed | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Al Respiratory Syncytial Virus Infections | Phase 3 | 2024-04-29 |
| Completed | A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults Respiratory Syncytial Virus Infections | Phase 3 | 2024-04-29 |
| Completed | A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Agains Influenza, Human | Phase 1 / Phase 2 | 2024-04-18 |
| Active Not Recruiting | Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Pa Asthma | Phase 4 | 2024-04-16 |
| Completed | A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combinati Tuberculosis | Phase 1 | 2024-04-05 |
| Terminated | A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis ( Idiopathic Pulmonary Fibrosis | Phase 2 | 2024-04-04 |
| Completed | A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Hu Gastroenteritis | Phase 3 | 2024-03-22 |
| Recruiting | A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Neoplasms, Head and Neck | Phase 3 | 2024-03-21 |
| Active Not Recruiting | REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a Asthma | Phase 4 | 2024-03-20 |
| Completed | Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH Non-alcoholic Fatty Liver Disease | Phase 2 | 2024-01-22 |
| Recruiting | A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nont Salmonella Infections | Phase 2 | 2024-01-15 |
| Suspended | A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK434 Systemic Lupus Erythematosus | Phase 1 | 2024-01-12 |
| Completed | A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Influenza, Human | Phase 4 | 2023-12-14 |
| Recruiting | A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants Malaria, Falciparum | Phase 1 | 2023-12-11 |
| Recruiting | A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease Pulmonary Disease, Chronic Obstructive | Phase 1 | 2023-11-27 |
| Terminated | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Mode Dermatitis, Atopic | Phase 2 | 2023-11-16 |
| Active Not Recruiting | A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positi Neoplasms, Head and Neck | Phase 2 | 2023-11-14 |
| Active Not Recruiting | A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Health Meningitis, Meningococcal | Phase 4 | 2023-11-10 |
| Withdrawn | A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants Colitis, Ulcerative | Phase 1 | 2023-10-31 |
| Active Not Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of Neoplasms | Phase 1 / Phase 2 | 2023-10-24 |
| Active Not Recruiting | Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2023-10-20 |
| Withdrawn | A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS Infections, Bacterial | Phase 2 | 2023-10-14 |
| Completed | A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Pr Hepatitis B | Phase 1 | 2023-10-04 |
| Completed | Concentration-QT Study of Paroxetine in Healthy Adults Anxiety Disorders | Phase 1 | 2023-10-02 |
| Terminated | A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain Pain | Phase 2 | 2023-09-20 |
| Recruiting | A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic | Phase 2 / Phase 3 | 2023-09-13 |
| Terminated | A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain, Osteoarthritis, Knee | Phase 2 | 2023-09-13 |
| Completed | Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) Anaemia | Phase 3 | 2023-09-06 |
| Completed | Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PC Gastroenteritis | Phase 3 | 2023-09-01 |
| Terminated | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placeb Hematologic Diseases, Anaemia, Sickle Cell | Phase 1 | 2023-08-26 |
| Completed | Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions Intestinal Diseases | Phase 1 | 2023-08-21 |
| Completed | A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy J Herpes Simplex | Phase 1 | 2023-08-08 |
| Completed | A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 20 COVID-19 | Phase 1 | 2023-08-07 |
| Completed | Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Influenza, Human | Phase 1 / Phase 2 | 2023-08-03 |
| Completed | A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults SARS-CoV-2, COVID-19 | Phase 2 | 2023-08-01 |
| Recruiting | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colo Colonic Neoplasms, Neoplasms, Colon | Phase 3 | 2023-08-01 |
| Completed | A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Respiratory Syncytial Virus Infections | Phase 2 | 2023-07-28 |
| Completed | A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vacc Respiratory Syncytial Viruses, Respiratory Syncytial Virus Infections | Phase 3 | 2023-07-28 |
| Completed | A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2023-07-07 |
| Recruiting | A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used a Multiple Myeloma | Phase 1 / Phase 2 | 2023-06-14 |
| Completed | A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Pulmonary Disease, Chronic Obstructive | Phase 4 | 2023-06-06 |
| Completed | Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Pr Respiratory Syncytial Virus Infections | Phase 3 | 2023-05-26 |
| Completed | A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older A Influenza, Human | Phase 1 / Phase 2 | 2023-04-27 |
| Recruiting | A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asth Asthma | Phase 3 | 2023-04-25 |
| Completed | Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years Urinary Tract Infections | Phase 1 | 2023-04-11 |
| Active Not Recruiting | A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer Neoplasms, Rectal | Phase 2 | 2023-04-03 |
| Completed | Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants Asthma | Phase 1 | 2023-04-03 |
| Withdrawn | A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab Arthritis, Rheumatoid | Phase 1 | 2023-02-08 |
| Completed | A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Respiratory Syncytial Virus Infections | Phase 3 | 2023-02-07 |
| Completed | Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 Pulmonary Disease, Chronic Obstructive | Phase 1 | 2023-01-23 |
| Completed | A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplic Urinary Tract Infections | Phase 3 | 2023-01-11 |
| Active Not Recruiting | Phase 2b Study of GSK4532990 in Adults With NASH Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease | Phase 2 | 2023-01-02 |
| Completed | A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared t Measles; Mumps; Rubella; Chickenpox, Measles | Phase 2 | 2022-12-14 |
| Completed | A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) Asthma | Phase 1 | 2022-12-13 |
| Active Not Recruiting | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) Chronic Hepatitis B, Hepatitis B, Chronic | Phase 3 | 2022-12-07 |
| Active Not Recruiting | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) Chronic Hepatitis B, Hepatitis B, Chronic | Phase 3 | 2022-12-06 |
| Completed | Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healt Sexually Transmitted Diseases | Phase 1 / Phase 2 | 2022-11-28 |
| Completed | Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Typhoid Fever | Phase 1 | 2022-11-28 |
| Recruiting | An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Influenza, Human, Arthralgia | Phase 2 | 2022-11-21 |
| Completed | Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Heal Infections, Soft Tissue | Phase 2 | 2022-11-16 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a S Dermatitis, Atopic | Phase 1 | 2022-11-04 |
| Completed | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50- Respiratory Syncytial Virus Infections | Phase 3 | 2022-10-28 |
| Completed | A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Respiratory Syncytial Virus Infections | Phase 3 | 2022-10-20 |
| Active Not Recruiting | A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metas Lung Cancer, Non-Small Cell | Phase 2 | 2022-10-14 |
| Completed | To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Pulmonary Disease, Chronic Obstructive | Phase 4 | 2022-10-14 |
| Completed | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Al Respiratory Syncytial Virus Infections | Phase 3 | 2022-10-14 |
| Completed | A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years Hepatitis B | Phase 1 | 2022-10-04 |
| Terminated | A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Phar Leukemia, Myeloid, Acute | Phase 1 | 2022-09-20 |
| Completed | A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nont Salmonella Infections | Phase 1 / Phase 2 | 2022-09-13 |
| Recruiting | Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial Hypereosinophilic Syndrome | Phase 3 | 2022-09-06 |
| Active Not Recruiting | Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomi Multiple Myeloma | Phase 1 / Phase 2 | 2022-08-31 |
| Completed | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | 2022-08-22 |
| Completed | Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adult COVID-19, SARS-CoV-2 | Phase 1 | 2022-08-12 |
| Completed | Food Effect Study of Linerixibat Tablets in Healthy Adult Participants Pruritus | Phase 1 | 2022-08-11 |
| Active Not Recruiting | A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoste Herpes Zoster | Phase 3 | 2022-08-10 |
| Completed | A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger an Influenza, Human | Phase 1 | 2022-08-09 |
| Completed | Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Est Tuberculosis | Phase 2 | 2022-07-26 |
| Active Not Recruiting | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethaso Multiple Myeloma | Phase 1 / Phase 2 | 2022-07-19 |
| Completed | Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls Pruritus | Phase 1 | 2022-07-19 |
| Active Not Recruiting | Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophil Eosinophilic Granulomatosis With Polyangiitis | Phase 3 | 2022-07-14 |
| Completed | Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) Hypereosinophilic Syndrome | Phase 3 | 2022-07-11 |
| Completed | Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated fo COVID-19 | Phase 4 | 2022-07-01 |
| Completed | A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infant Pneumonia, Bacterial, Pneumococcal Infections, Pneumonia, Pneumococcal | Phase 2 | 2022-06-16 |
| Completed | Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Partici Pulmonary Disease, Chronic Obstructive | Phase 1 | 2022-06-09 |
| Completed | Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants W Uncomplicated Urinary Tract Infections, Urinary Tract Infections | Phase 1 | 2022-05-18 |
| Active Not Recruiting | Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditi Herpes Zoster | — | 2022-05-09 |
| Completed | Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Oti Otitis Media, Infections, Respiratory Tract, Respiratory Tract Infections | Phase 4 | 2022-05-07 |
| Completed | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps Nasal Polyps | Phase 3 | 2022-04-22 |
| Withdrawn | A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasti Healthy Volunteers | Phase 1 | 2022-04-21 |
| Completed | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps Nasal Polyps | Phase 3 | 2022-04-18 |
| Active Not Recruiting | Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection Hepatitis B | Phase 1 / Phase 2 | 2022-04-14 |
| Completed | Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adu COVID-19, SARS-CoV-2 | Phase 1 | 2022-03-24 |
| Active Not Recruiting | First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors Neoplasms | Phase 1 | 2022-03-22 |
| Completed | A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonuc Hepatitis B, Chronic | Phase 2 | 2022-03-22 |
| Withdrawn | A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Fema Respiratory Syncytial Virus Infections | Phase 3 | 2022-03-11 |
| Completed | A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV i Herpes Simplex | Phase 1 / Phase 2 | 2022-03-07 |
| Active Not Recruiting | Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refr Multiple Myeloma | Phase 2 | 2022-03-03 |
| Completed | A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healt Healthy Volunteers | Phase 1 | 2022-03-01 |
| Completed | An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 2067 Asthma | Phase 3 | 2022-03-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and J Pain | Phase 1 | 2022-02-14 |
| Withdrawn | Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fa Healthy Volunteers | Phase 1 | 2022-02-13 |
| Active Not Recruiting | All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Multiple Myeloma | Phase 3 | 2022-02-10 |
| Completed | A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compar Chickenpox | Phase 2 | 2022-02-03 |
| Completed | A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-preg Respiratory Syncytial Virus Infections | Phase 3 | 2022-02-02 |
| Completed | A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older Herpes Zoster | Phase 3 | 2022-02-02 |
| Completed | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer Neoplasms | Phase 2 | 2021-12-23 |
| Terminated | Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants W COVID-19 | Phase 2 | 2021-12-16 |
| Terminated | Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials Neoplasms | Phase 2 | 2021-12-16 |
| Recruiting | Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Particip Hepatitis B | Phase 2 | 2021-12-14 |
| Completed | Study of GSK3511294 in Healthy Chinese Participants Asthma | Phase 1 | 2021-12-10 |
| Completed | A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Inf Infections, Meningococcal | Phase 2 | 2021-11-29 |
| Completed | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants Pruritus | Phase 1 | 2021-11-23 |
| Completed | Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis Dermatitis, Atopic | Phase 1 | 2021-11-18 |
| Active Not Recruiting | Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Ado Meningitis, Meningococcal | Phase 2 | 2021-11-18 |
| Completed | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Multiple Sclerosis, Colitis, Ulcerative | Phase 1 | 2021-11-01 |
| Completed | A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the I Respiratory Syncytial Virus Infections | Phase 3 | 2021-10-26 |
| Completed | Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lup Systemic Lupus Erythematosus | Phase 4 | 2021-10-21 |
| Completed | A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults Cytomegalovirus Infections | Phase 1 / Phase 2 | 2021-10-14 |
| Completed | A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Giv Herpes Zoster | Phase 3 | 2021-10-07 |
| Completed | A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Diarrhoea | Phase 1 | 2021-10-06 |
| Completed | A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Ye Respiratory Syncytial Virus Infections | Phase 3 | 2021-10-01 |
| Terminated | A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Heart Failure | Phase 1 | 2021-09-20 |
| Completed | Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Particip Systemic Lupus Erythematosus | — | 2021-09-14 |
| Completed | Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment Hepatitis B | Phase 1 | 2021-09-07 |
| Completed | Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) Pruritus | Phase 3 | 2021-08-27 |
| Terminated | A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Respiratory Syncytial Virus Infections | Phase 3 | 2021-08-03 |
| Completed | Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With I Asthma | Phase 3 | 2021-07-29 |
| Active Not Recruiting | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM Multiple Myeloma | Phase 1 / Phase 2 | 2021-07-29 |
| Active Not Recruiting | Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethason Multiple Myeloma | Phase 3 | 2021-07-28 |
| Active Not Recruiting | China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone V Multiple Myeloma | Phase 3 | 2021-07-28 |
| Completed | Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Grea Asthma | Phase 4 | 2021-06-29 |
| Active Not Recruiting | Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Ne Neoplasms, Breast | Phase 3 | 2021-06-28 |
| Completed | A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Ad Infections, Meningococcal | Phase 1 / Phase 2 | 2021-06-14 |
| Completed | An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Herpes Genitalis | — | 2021-06-09 |
| Completed | A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/H Diphtheria | Phase 4 | 2021-05-26 |
| Completed | Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Respiratory Syncytial Virus Infections | Phase 3 | 2021-05-25 |
| Terminated | Molecular Disease Characterization Initiative (MDCI) Lung Cancer, Non-Small Cell, Neoplasms | Phase 2 | 2021-05-25 |
| Completed | Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Herpes Zoster | Phase 4 | 2021-05-14 |
| Completed | Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China Pulmonary Disease, Chronic Obstructive | — | 2021-04-27 |
| Completed | A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Respiratory Syncytial Virus Infections | Phase 3 | 2021-04-27 |
| Completed | Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophi Nasal Polyps | Phase 3 | 2021-04-22 |
| Withdrawn | A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function Multiple Myeloma | Phase 1 | 2021-04-20 |
| Recruiting | A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESAR Ovarian Neoplasms, Breast Neoplasms | Phase 2 | 2021-04-16 |
| Completed | A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLI Asthma | Phase 4 | 2021-04-14 |
| Withdrawn | Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease Crohns Disease, Crohn's Disease | Phase 2 | 2021-04-05 |
| Completed | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma Wi Asthma | Phase 3 | 2021-03-17 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641 Influenza, Human | Phase 2 | 2021-03-16 |
| Terminated | Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) Relapsed/Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2021-03-09 |
| Terminated | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer Neoplasms | Phase 2 | 2021-03-04 |
| Completed | Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms Sunscreening Agents | N/A | 2021-03-03 |
| Completed | Substance P Challenge in Healthy Participants Skin Diseases | N/A | 2021-03-02 |
| Terminated | A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Herpes Simplex | Phase 1 | 2021-03-02 |
| Completed | A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults Virus Diseases | Phase 1 | 2021-02-15 |
| Active Not Recruiting | Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus Infections | Phase 3 | 2021-02-15 |
| Completed | A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Gingivitis | Phase 2 | 2021-02-10 |
| Completed | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype Asthma | Phase 3 | 2021-02-04 |
| Completed | Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) Hepatitis B | Phase 2 | 2021-01-28 |
| Completed | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asth Asthma | Phase 3 | 2021-01-26 |
| Completed | Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed Meningitis, Meningococcal | Phase 3 | 2021-01-25 |
| Completed | Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants Pulmonary Disease, Chronic Obstructive | — | 2021-01-14 |
| Terminated | Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin Multiple Myeloma | Phase 3 | 2020-12-21 |
| Completed | Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissoluti Anaemia | Phase 1 | 2020-12-18 |
| Completed | Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis | — | 2020-12-11 |
| Completed | Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investiga Respiratory Syncytial Virus Infections | Phase 2 | 2020-12-09 |
| Completed | Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants Anxiety Disorders | Phase 1 | 2020-12-09 |
| Active Not Recruiting | Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Pa Lung Cancer, Non-Small Cell | Phase 3 | 2020-12-08 |
| Terminated | A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Preg Respiratory Syncytial Virus Infections | Phase 3 | 2020-11-20 |
| Terminated | Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants Wi Lung Cancer, Non-Small Cell | Phase 2 | 2020-11-19 |
| Completed | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Celiac Disease, Coeliac Disease | Phase 1 | 2020-11-04 |
| Terminated | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants Tuberculosis | Phase 1 | 2020-10-30 |
| Active Not Recruiting | Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenan Lung Cancer, Non-Small Cell | Phase 3 | 2020-10-26 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Ad Neoplasms | Phase 1 | 2020-10-15 |
| Completed | Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable A Pulmonary Disease, Chronic Obstructive | Phase 1 | 2020-10-12 |
| Completed | A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulation Skin Care | N/A | 2020-10-12 |
| Active Not Recruiting | A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Multiple Myeloma | Phase 1 | 2020-10-09 |
| Terminated | Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Neoplasms | Phase 1 | 2020-10-06 |
| Completed | A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B Hepatitis B | Phase 2 | 2020-10-06 |
| Withdrawn | A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Ad Denture Retention | Phase 3 | 2020-10-04 |
| Active Not Recruiting | Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma | Phase 3 | 2020-10-01 |
| Completed | Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants Leishmaniasis | Phase 1 | 2020-09-29 |
| Completed | A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants Psoriasis | Phase 1 | 2020-09-28 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Particip Macular Edema | Phase 1 | 2020-09-07 |
| Completed | Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomita Infections, Meningococcal | Phase 3 | 2020-08-25 |
| Completed | Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants. Urinary Tract Infections | Phase 1 | 2020-08-24 |
| Completed | Drug-drug Interaction Study of Gepotidacin Infections, Bacterial | Phase 1 | 2020-08-14 |
| Completed | Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Health Infections, Meningococcal | Phase 3 | 2020-08-14 |
| Terminated | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Re Neoplasms, Head and Neck | Phase 3 | 2020-08-12 |
| Completed | A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) Hepatitis B | Phase 2 | 2020-07-27 |
| Completed | A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab Healthy Volunteers, Asthma | Phase 1 | 2020-07-21 |
| Active Not Recruiting | Linerixibat Long-term Safety, and Tolerability Study Cholestasis | Phase 3 | 2020-07-14 |
| Active Not Recruiting | Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors Neoplasms | Phase 1 | 2020-06-25 |
| Active Not Recruiting | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM Multiple Myeloma | Phase 1 / Phase 2 | 2020-06-08 |
| Completed | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease Severe Acute Respiratory Syndrome | Phase 2 | 2020-05-28 |
| Terminated | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) Arthritis, Rheumatoid | Phase 3 | 2020-05-12 |
| Active Not Recruiting | Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bo Multiple Myeloma | Phase 3 | 2020-05-07 |
| Completed | Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicat Urinary Tract Infections | Phase 3 | 2020-04-23 |
| Completed | Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China Pulmonary Disease, Chronic Obstructive | — | 2020-04-22 |
| Active Not Recruiting | Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Partic Multiple Myeloma | Phase 3 | 2020-04-02 |
| Completed | Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportion Antifungal Agents | Phase 1 | 2020-01-13 |
| Active Not Recruiting | Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 1 | 2019-12-18 |
| Completed | A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Prev Herpes Zoster | Phase 3 | 2019-12-09 |
| Completed | A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clin Multiple Myeloma | Phase 1 | 2019-12-09 |
| Completed | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants Healthy Volunteers | Phase 1 | 2019-12-05 |
| Active Not Recruiting | Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 2 | 2019-11-28 |
| Active Not Recruiting | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants Wi Multiple Myeloma | Phase 1 / Phase 2 | 2019-11-26 |
| Terminated | Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Me Neoplasms, Head and Neck | Phase 3 | 2019-11-21 |
| Completed | A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Ag Respiratory Syncytial Virus Infections | Phase 2 | 2019-11-05 |
| Completed | Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus Infections | Phase 2 | 2019-11-05 |
| Completed | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to S Arthritis, Rheumatoid | Phase 3 | 2019-10-31 |
| Completed | Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinoph Pulmonary Disease, Chronic Obstructive | Phase 3 | 2019-10-30 |
| Completed | Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intrave Systemic Lupus Erythematosus | Phase 1 | 2019-10-28 |
| Recruiting | A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children W Herpes Zoster | Phase 1 / Phase 2 | 2019-10-25 |
| Completed | Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study Pain | Phase 3 | 2019-10-24 |
| Completed | A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treat Gonorrhea | Phase 3 | 2019-10-21 |
| Completed | A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infecti Urinary Tract Infections | Phase 3 | 2019-10-17 |
| Terminated | Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers Pain | Phase 1 | 2019-10-15 |
| Terminated | Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants Relapsed/Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2019-10-07 |
| Completed | A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health Aft Gingivitis | Phase 4 | 2019-10-07 |
| Active Not Recruiting | Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Partic Multiple Myeloma | Phase 2 | 2019-10-07 |
| Completed | Efficacy of Manual Toothbrushes in Removing Dental Plaque Dental Plaque, Oral Hygiene | N/A | 2019-09-30 |
| Completed | Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants Hypertension, Pulmonary | Phase 1 | 2019-09-30 |
| Terminated | Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Neoplasms | Phase 1 | 2019-09-26 |
| Completed | A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Respiratory Syncytial Virus Infections | Phase 1 | 2019-09-25 |
| Completed | Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two Herpes Zoster | Phase 3 | 2019-09-17 |
| Completed | Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects Infections, Bacterial | Phase 1 | 2019-09-04 |
| Completed | To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products Skin Care | N/A | 2019-08-30 |
| Completed | A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion Skin Care | N/A | 2019-08-28 |
| Completed | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects Cholestasis | Phase 1 | 2019-08-27 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Va Virus Diseases | Phase 1 | 2019-08-13 |
| Completed | Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy A Clostridium Infections | Phase 1 | 2019-08-05 |
| Completed | Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND Anaemia | Phase 2 | 2019-07-30 |
| Completed | Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Infections, Rotavirus | Phase 3 | 2019-07-19 |
| Completed | Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants Dental Plaque | Phase 2 | 2019-07-08 |
| Completed | Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat Cholestasis | Phase 1 | 2019-07-08 |
| Withdrawn | Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study Pulmonary Disease, Chronic Obstructive | Phase 4 | 2019-06-27 |
| Completed | Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan Pulmonary Disease, Chronic Obstructive | — | 2019-06-13 |
| Completed | Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Healthy Volunteers | Phase 1 | 2019-06-10 |
| Terminated | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely A Arthritis, Rheumatoid | Phase 3 | 2019-06-05 |
| Completed | Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients Pulmonary Disease, Chronic Obstructive | — | 2019-06-03 |
| Completed | A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance Respiratory Syncytial Virus Infections | N/A | 2019-05-30 |
| Completed | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely A Arthritis, Rheumatoid | Phase 3 | 2019-05-16 |
| Completed | Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity Dentin Hypersensitivity, Dentin Sensitivity | Phase 2 | 2019-05-13 |
| Terminated | Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis Colitis, Ulcerative | Phase 2 | 2019-05-06 |
| Terminated | Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects Leishmaniasis | Phase 1 | 2019-04-30 |
| Completed | Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Hea Respiratory Disorders | Phase 2 | 2019-04-23 |
| Completed | Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 6 Gingivitis, Dental Plaque | — | 2019-04-17 |
| Completed | Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexpose Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | 2019-04-08 |
| Terminated | Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (G Hepatitis B, Chronic | Phase 1 / Phase 2 | 2019-03-28 |
| Completed | An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonar Tuberculosis | Phase 2 | 2019-03-22 |
| Completed | A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccin Malaria, Malaria Vaccines | — | 2019-03-21 |
| Completed | An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Ha Multiple Myeloma | Phase 1 | 2019-03-14 |
| Completed | Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Multiple Myeloma | Phase 1 / Phase 2 | 2019-03-14 |
| Active Not Recruiting | A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors Neoplasms | Phase 1 | 2019-03-12 |
| Withdrawn | Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination Neoplasms | Phase 2 | 2019-02-25 |
| Completed | Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavi Rotavirus | Phase 3 | 2019-02-20 |
| Completed | Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in th Whooping Cough | — | 2019-02-15 |
| Completed | A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Bo Malaria | Phase 2 | 2019-02-05 |
| Completed | To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive Denture Retention | Phase 3 | 2019-02-04 |
| Completed | A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Pneumonia, Bacterial, Healthy Volunteers, Pneumococcal Disease | Phase 1 / Phase 2 | 2019-01-24 |
| Completed | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer Neoplasms | Phase 2 | 2019-01-24 |
| Completed | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer Neoplasms | Phase 2 | 2019-01-24 |
| Completed | To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function Dry Skin, Skin Care | N/A | 2019-01-22 |
| Withdrawn | A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma Asthma | Phase 2 | 2019-01-21 |
| Completed | A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investi Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | 2019-01-21 |
| Withdrawn | Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System Asthma | Phase 3 | 2019-01-18 |
| Terminated | Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) D Anaemia | Phase 2 | 2019-01-10 |
| Completed | A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers Denture Retention | Phase 4 | 2019-01-07 |
| Terminated | Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Sq Neoplasms | Phase 1 / Phase 2 | 2018-12-31 |
| Completed | GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors Neoplasms | Phase 1 / Phase 2 | 2018-11-26 |
| Completed | Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yea Malaria | — | 2018-11-19 |
| Terminated | First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults Neoplasms, Pancreatic | Phase 2 | 2018-11-16 |
| Completed | A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Sy Respiratory Syncytial Virus Infections | Phase 1 | 2018-10-30 |
| Terminated | First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lym Neoplasms | Phase 1 | 2018-10-22 |
| Terminated | Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Neoplasms | Phase 1 / Phase 2 | 2018-10-16 |
| Completed | A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formu Skin Care | N/A | 2018-10-15 |
| Completed | Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the Influenza, Human | Phase 4 | 2018-10-05 |
| Completed | A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Neoplasms, Rectal | — | 2018-10-02 |
| Withdrawn | A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hype Dentin Sensitivity | Phase 2 | 2018-10-01 |
| Completed | A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations Autoimmune Diseases | Phase 1 | 2018-09-26 |
| Completed | Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects Asthma | — | 2018-09-21 |
| Completed | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administere Multiple Myeloma | Phase 1 / Phase 2 | 2018-09-20 |
| Completed | A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococc Infections, Meningococcal | Phase 2 | 2018-09-07 |
| Completed | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Anaemia | Phase 3 | 2018-09-05 |
| Completed | First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Muscular Dystrophies | Phase 1 | 2018-08-30 |
| Completed | A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococc Meningitis, Meningococcal | Phase 2 | 2018-08-30 |
| Completed | A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection Dysentery, Bacillary | Phase 2 | 2018-08-29 |
| Completed | A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma Asthma | Phase 3 | 2018-08-29 |
| Completed | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed ( Cervical Intraepithelial Neoplasia | Phase 4 | 2018-08-22 |
| Completed | Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Infections, Meningococcal | Phase 3 | 2018-07-27 |
| Completed | Sensor and Electronic Health Records (EHR) Integration Pilot Study Pulmonary Disease, Chronic Obstructive | — | 2018-07-23 |
| Completed | Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection Infections, Bacterial | Phase 2 | 2018-07-23 |
| Unknown | BOTOX® Drug Use Investigation (Spasmodic Dysphonia) Dysphonia | — | 2018-07-20 |
| Completed | A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee Pain | Phase 1 | 2018-07-19 |
| Completed | Phase I Study of GSK2982772 in Japanese Healthy Male Participants Autoimmune Diseases | Phase 1 | 2018-07-19 |
| Withdrawn | Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects Amyloidosis | Phase 1 | 2018-07-12 |
| Completed | Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Admi Meningitis, Meningococcal | Phase 2 | 2018-07-09 |
| Completed | NUCALA® Special Drug Use Investigation (EGPA, Long-term) Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis | — | 2018-06-25 |
| Completed | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Pulmonary Disease, Chronic Obstructive | Phase 4 | 2018-06-25 |
| Terminated | Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model Healthy Volunteers | Phase 1 | 2018-06-25 |
| Completed | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple T Pulmonary Disease, Chronic Obstructive | Phase 4 | 2018-06-25 |
| Completed | An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asth Asthma | Phase 4 | 2018-06-18 |
| Completed | To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) i Tobacco Use Disorder | Phase 1 | 2018-06-18 |
| Completed | A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myelom Multiple Myeloma | Phase 2 | 2018-06-18 |
| Completed | A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers Tobacco Use Disorder | Phase 1 | 2018-06-18 |
| Completed | Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impa Infections, Bacterial | Phase 1 | 2018-06-14 |
| Completed | Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP) Sjogren's Syndrome | — | 2018-06-13 |
| Terminated | Study of Renin-angiotensin System in Mechanically Ventilated Subjects Acute Lung Injury | N/A | 2018-06-11 |
| Completed | A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022 Herpes Zoster | — | 2018-06-05 |
| Withdrawn | A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Autoimmune Diseases | Phase 1 | 2018-06-01 |
| Completed | A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Pa Cervical Intraepithelial Neoplasia | — | 2018-05-31 |
| Completed | Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness Pulmonary Disease, Chronic Obstructive | — | 2018-05-31 |
| Completed | Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSK Anxiety Disorders | Phase 1 | 2018-05-30 |
| Terminated | Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccinatio Diphtheria-Tetanus-Acellular Pertussis | Phase 4 | 2018-05-29 |
| Completed | Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Rele Rhinitis | Phase 1 | 2018-05-18 |
| Completed | A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Partic Pain, Inflammatory | Phase 1 | 2018-05-17 |
| Withdrawn | Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccina Hepatitis A | Phase 4 | 2018-05-07 |
| Active Not Recruiting | Extended Access of Momelotinib in Adults With Myelofibrosis Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF) | Phase 2 | 2018-05-03 |
| Completed | Daprodustat Bioequivalence and Food Effect Study Anaemia | Phase 1 | 2018-04-24 |
| Completed | Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impac Pulmonary Disease, Chronic Obstructive | — | 2018-04-19 |
| Terminated | Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Dis Asthma | Phase 2 | 2018-04-18 |
| Recruiting | The Extended Salford Lung Study ("Ex-SLS") Data Access Project Asthma | — | 2018-04-15 |
| Completed | The Safety of Boostrix Following Routine Immunization of Pregnant Women Whooping Cough | — | 2018-04-13 |
| Completed | Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered Wit Herpes Zoster | Phase 3 | 2018-04-12 |
| Completed | INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design Pulmonary Disease, Chronic Obstructive | Phase 4 | 2018-04-11 |
| Completed | Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) fo Malaria, Vivax | Phase 3 | 2018-04-08 |
| Terminated | Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging Amyloidosis | Phase 1 | 2018-04-06 |
| Terminated | A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough Cough | Phase 1 / Phase 2 | 2018-04-05 |
| Completed | A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple The Pulmonary Disease, Chronic Obstructive | Phase 4 | 2018-03-29 |
| Completed | Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors Neoplasms | Phase 1 | 2018-03-26 |
| Completed | A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old a Respiratory Disorders | Phase 2 | 2018-03-20 |
| Withdrawn | Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica Polymyalgia Rheumatica | Phase 3 | 2018-03-15 |
| Terminated | First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Si Arthritis, Rheumatoid | Phase 1 | 2018-03-13 |
| Completed | A Sourcing Study to Collect Human Blood Samples From Healthy Adults Meningitis, Meningococcal | Phase 4 | 2018-03-08 |
| Completed | GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects Pulmonary Disease, Chronic Obstructive | Phase 1 | 2018-03-07 |
| Withdrawn | The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma Asthma | Phase 4 | 2018-03-07 |
| Completed | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Anaemia | Phase 3 | 2018-03-05 |
| Completed | To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers Common Cold | Phase 1 | 2018-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult S Systemic Lupus Erythematosus | Phase 3 | 2018-03-01 |
| Completed | A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Cervical Intraepithelial Neoplasia | Phase 3 | 2018-02-28 |
| Completed | Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2 Cachexia | Phase 2 | 2018-02-28 |
| Completed | A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) Hypertension, Pulmonary | Phase 2 | 2018-02-21 |
| Withdrawn | A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vacc Virus Diseases | Phase 4 | 2018-02-15 |
| Completed | Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixim Infections, Bacterial | Phase 1 | 2018-02-06 |
| Completed | A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Ther Asthma | Phase 4 | 2018-01-31 |
| Completed | Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Airway Obstruction | — | 2018-01-29 |
| Terminated | Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants Burns | Phase 1 | 2018-01-29 |
| Completed | Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | 2018-01-26 |
| Completed | Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS) Wiskott-Aldrich Syndrome | — | 2018-01-24 |
| Withdrawn | GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis Psoriasis | Phase 3 | 2018-01-22 |
| Completed | A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib Pulmonary Disease, Chronic Obstructive | Phase 1 | 2018-01-17 |
| Completed | BENLYSTA® Special Drug Use Investigation Systemic Lupus Erythematosus | — | 2018-01-15 |
| Terminated | GSK2983559 First Time in Human Study Inflammatory Bowel Diseases | Phase 1 | 2018-01-11 |
| Withdrawn | A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fas Infections, Bacterial | Phase 1 | 2018-01-11 |
| Completed | Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 Asthma | — | 2018-01-09 |
| Completed | Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function Neoplasms | — | 2017-12-20 |
| Completed | Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) Infection, Human Immunodeficiency Virus, HIV Infections | Phase 1 | 2017-12-14 |
| Withdrawn | A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects Psoriasis | Phase 1 | 2017-12-14 |
| Completed | Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Disease, Chronic Obstructive | — | 2017-12-05 |
| Completed | Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer Neoplasms | — | 2017-12-04 |
| Completed | A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma Asthma | — | 2017-12-01 |
| Withdrawn | Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at Diphtheria, Acellular Pertussis, Haemophilus Influenzae Type b | Phase 3 | 2017-12-01 |
| Terminated | Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Ch Pulmonary Disease, Chronic Obstructive | Phase 2 | 2017-11-28 |
| Withdrawn | A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Solid Tumours | Phase 2 | 2017-11-27 |
| Completed | A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 4 Respiratory Disorders | Phase 2 | 2017-11-27 |
| Completed | Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects Hypertension, Pulmonary | — | 2017-11-22 |
| Completed | Prevalence of Severe Asthma in Spanish Hospitals Asthma | — | 2017-11-22 |
| Completed | Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease Lung Diseases, Interstitial | — | 2017-11-21 |
| Completed | A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers Denture Retention | N/A | 2017-11-20 |
| Completed | A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity Dentin Sensitivity | N/A | 2017-11-18 |
| Terminated | Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstru Pulmonary Disease, Chronic Obstructive | Phase 2 | 2017-11-15 |
| Completed | Absorption & Elimination of Radiolabelled GSK2269557 Pulmonary Disease, Chronic Obstructive | Phase 1 | 2017-11-14 |
| Completed | In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste Tooth Erosion | Phase 3 | 2017-11-13 |
| Completed | A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome Hypereosinophilic Syndrome | Phase 3 | 2017-11-13 |
| Completed | Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to F Asthma | Phase 3 | 2017-10-20 |
| Completed | Pediatric Ease of Use ELLIPTA Items Asthma | — | 2017-10-17 |
| Completed | First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and P Asthma | Phase 1 | 2017-10-17 |
| Terminated | A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Disease, Chronic Obstructive | Phase 2 | 2017-10-16 |
| Completed | A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects Autoimmune Diseases | Phase 1 | 2017-10-11 |
| Completed | Absorption and Elimination of Radiolabeled Daprodustat Anaemia | Phase 1 | 2017-10-10 |
| Completed | The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After On Virus Diseases | Phase 4 | 2017-10-05 |
| Completed | A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Hepatitis B, Chronic | Phase 4 | 2017-10-02 |
| Withdrawn | Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volu Alzheimer's Disease | Phase 1 | 2017-10-01 |
| Completed | Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Malaria | Phase 2 | 2017-09-28 |
| Completed | A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Rele Autoimmune Diseases | Phase 1 | 2017-09-27 |
| Completed | A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifric Oral Hygiene | Phase 2 | 2017-09-25 |
| Completed | Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects Toxoplasmosis | Phase 1 | 2017-09-25 |
| Completed | Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects W Pulmonary Disease, Chronic Obstructive | Phase 4 | 2017-09-20 |
| Completed | To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population Gingivitis | N/A | 2017-09-19 |
| Withdrawn | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Prima Autoimmune Diseases | Phase 2 | 2017-09-19 |
| Completed | This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix Rotavirus Infection, Rotavirus Vaccines | Phase 3 | 2017-09-14 |
| Completed | Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma Asthma | Phase 2 | 2017-09-14 |
| Completed | Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England Influenza, Human | — | 2017-09-12 |
| Completed | Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Coun Influenza, Human | — | 2017-09-11 |
| Completed | A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Invest Influenza, Human | Phase 1 | 2017-09-08 |
| Completed | RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term) Pulmonary Disease, Chronic Obstructive | — | 2017-08-30 |
| Completed | Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and Duri Respiratory Disorders | N/A | 2017-08-25 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infu Pancreatitis, Acute Necrotizing | Phase 1 | 2017-08-22 |
| Completed | Arnuity® Ellipta® Drug Use Investigation Asthma | — | 2017-08-19 |
| Terminated | Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Mu Neoplasms | Phase 1 | 2017-08-18 |
| Withdrawn | A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Dia Diabetes Mellitus, Type 2 | Phase 3 | 2017-08-14 |
| Completed | Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healt Arthritis, Rheumatoid | Phase 1 | 2017-08-11 |
| Completed | Study of Subjects With Diabetic Foot Ulcer (DFU) Diabetic Foot | — | 2017-08-11 |
| Completed | A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersens Dentin Sensitivity | Phase 2 | 2017-08-07 |